Literature DB >> 21730148

D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex.

Yan-Chun Li1, Christoph Kellendonk, Eleanor H Simpson, Eric R Kandel, Wen-Jun Gao.   

Abstract

Two distinct defects are thought to be important for the pathophysiology of schizophrenia. One is an increase of D2 receptors (D2Rs) in the striatum and another is a decrease in the GABAergic function in the prefrontal cortex (PFC). Whether these two defects are functionally linked is not known. We previously reported that selective overexpression of D2Rs in the striatum of the mouse causes behavioral abnormality associated with PFC functions. Using patch-clamp recording, we find that overexpression of D2Rs in the striatum affects inhibitory transmission in the PFC and dopamine (DA) sensitivity. The overexpression of D2Rs in the striatum caused an increase in frequency of spontaneous excitatory postsynaptic currents (EPSCs) in layer V pyramidal neurons, whereas their neuronal excitability was unaffected. In contrast, both the frequency and amplitude of spontaneous inhibitory postsynaptic currents (sIPSCs) were significantly decreased in these mice, indicating a reduced inhibitory transmission. Furthermore, in D2R transgenic mice the dopaminergic modulation of evoked IPSCs was shifted, with reduced sensitivity. The change in dopamine sensitivity in the PFC of D2R transgenic mice appears specific for D2Rs because in D2R transgenic mice the effects of D2 agonist but not D1 agonist, on both evoked IPSCs and EPSCs, were reduced. Together, these results indicate that overexpression of D2Rs in the striatum leads to a functional deficit in the GABAergic system. These results provide a functional link between D2R overexpression and GABAergic inhibition in the PFC and suggest that the postulated deficit in GABAergic function in schizophrenia could be secondary to alterations in the striatal dopamine system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730148      PMCID: PMC3141950          DOI: 10.1073/pnas.1109718108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics.

Authors:  C L Beasley; G P Reynolds
Journal:  Schizophr Res       Date:  1997-04-11       Impact factor: 4.939

2.  Dopaminergic stimulation of local protein synthesis enhances surface expression of GluR1 and synaptic transmission in hippocampal neurons.

Authors:  W Bryan Smith; Shelley R Starck; Richard W Roberts; Erin M Schuman
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

3.  Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning.

Authors:  Suzanne N Haber; Ki-Sok Kim; Philippe Mailly; Roberta Calzavara
Journal:  J Neurosci       Date:  2006-08-09       Impact factor: 6.167

Review 4.  Dopamine, the prefrontal cortex and schizophrenia.

Authors:  M B Knable; D R Weinberger
Journal:  J Psychopharmacol       Date:  1997       Impact factor: 4.153

5.  Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia.

Authors:  Kuei-Yuan Tseng; Barbara L Lewis; Barbara K Lipska; Patricio O'Donnell
Journal:  Biol Psychiatry       Date:  2007-01-03       Impact factor: 13.382

6.  Mechanisms underlying differential D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex.

Authors:  Heather Trantham-Davidson; Laurence C Neely; Antonieta Lavin; Jeremy K Seamans
Journal:  J Neurosci       Date:  2004-11-24       Impact factor: 6.167

7.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.

Authors:  M Akil; J N Pierri; R E Whitehead; C L Edgar; C Mohila; A R Sampson; D A Lewis
Journal:  Am J Psychiatry       Date:  1999-10       Impact factor: 18.112

Review 8.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

9.  Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

Authors:  Christoph Kellendonk; Eleanor H Simpson; H Jonathan Polan; Gaël Malleret; Svetlana Vronskaya; Vanessa Winiger; Holly Moore; Eric R Kandel
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

10.  Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing.

Authors:  Michael R Drew; Eleanor H Simpson; Christoph Kellendonk; William G Herzberg; Olga Lipatova; Stephen Fairhurst; Eric R Kandel; Chara Malapani; Peter D Balsam
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

View more
  44 in total

Review 1.  Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

Authors:  Meng-Lin Li; Xi-Quan Hu; Feng Li; Wen-Jun Gao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-24       Impact factor: 5.067

Review 2.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 3.  Dopamine receptors - IUPHAR Review 13.

Authors:  Jean-Martin Beaulieu; Stefano Espinoza; Raul R Gainetdinov
Journal:  Br J Pharmacol       Date:  2015-01       Impact factor: 8.739

Review 4.  Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior.

Authors:  Eduardo F Gallo
Journal:  Neurochem Int       Date:  2019-02-01       Impact factor: 3.921

Review 5.  Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Jared W Young
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

6.  NOX1/NADPH Oxidase Promotes Synaptic Facilitation Induced by Repeated D2 Receptor Stimulation: Involvement in Behavioral Repetition.

Authors:  Nozomi Asaoka; Masakazu Ibi; Hikari Hatakama; Koki Nagaoka; Kazumi Iwata; Misaki Matsumoto; Masato Katsuyama; Shuji Kaneko; Chihiro Yabe-Nishimura
Journal:  J Neurosci       Date:  2021-02-09       Impact factor: 6.167

7.  A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice.

Authors:  S Edut; V Rubovitch; M Rehavi; S Schreiber; C G Pick
Journal:  J Mol Neurosci       Date:  2014-08-16       Impact factor: 3.444

8.  Dopamine D1 or D2 receptor-expressing neurons in the central nervous system.

Authors:  Xiaoyan Wei; Tengfei Ma; Yifeng Cheng; Cathy C Y Huang; Xuehua Wang; Jiayi Lu; Jun Wang
Journal:  Addict Biol       Date:  2017-04-24       Impact factor: 4.280

Review 9.  Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis.

Authors:  Andrew M Rosen; Timothy Spellman; Joshua A Gordon
Journal:  Biol Psychiatry       Date:  2015-03-27       Impact factor: 13.382

10.  The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia.

Authors:  Ryan D Ward; Vanessa Winiger; Kerin K Higa; Julia B Kahn; Eric R Kandel; Peter D Balsam; Eleanor H Simpson
Journal:  Behav Neurosci       Date:  2015-04-27       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.